TH1801003732A - GEMSITABINE - [Phenyl-Benzoxi-L-Alanilan)] - Phosphate, or salts or solvets of such things that are pharmacologically acceptable for use in Cancer treatment and the aforementioned holistic packages - Google Patents

GEMSITABINE - [Phenyl-Benzoxi-L-Alanilan)] - Phosphate, or salts or solvets of such things that are pharmacologically acceptable for use in Cancer treatment and the aforementioned holistic packages

Info

Publication number
TH1801003732A
TH1801003732A TH1801003732A TH1801003732A TH1801003732A TH 1801003732 A TH1801003732 A TH 1801003732A TH 1801003732 A TH1801003732 A TH 1801003732A TH 1801003732 A TH1801003732 A TH 1801003732A TH 1801003732 A TH1801003732 A TH 1801003732A
Authority
TH
Thailand
Prior art keywords
alanilan
benzoxi
holistic
phenyl
phosphate
Prior art date
Application number
TH1801003732A
Other languages
Thai (th)
Inventor
กริฟฟิท
ฮิวจ์
Original Assignee
นางดารานีย์ วัจนะวุฒิวงศ์
นางสาวสนธยา สังขพงศ์
นางสาวสุคนธ์ทิพย์ จิตมงคลทอง
Filing date
Publication date
Application filed by นางดารานีย์ วัจนะวุฒิวงศ์, นางสาวสนธยา สังขพงศ์, นางสาวสุคนธ์ทิพย์ จิตมงคลทอง filed Critical นางดารานีย์ วัจนะวุฒิวงศ์
Publication of TH1801003732A publication Critical patent/TH1801003732A/en

Links

Claims (1)

: ข้อถือสิทธิ์ (ข้อที่หนึ่ง) ซึ่งจะปรากฏบนหน้าประกาศโฆษณา : แก้ไข 12/09/2561 ข้อถือสิทธิ: Claims (number one) which will appear on the advertisement page: edit 12/09/2018 1. เจมซิทาบีน-[ฟีนิล-เบนซอกซี-L-อะลานินิล)]-ฟอสเฟท, หรือเกลือหรือโซลเวทของ สิ่งดังกล่าวที่สามารถยอมรับได้ทางเภสัชกรรมสำหรับการใช้ในการรักษาโรคมะเร็งในองค์รวมกับ สารต่อด้านโรคมะเร็งที่มีพื้นฐานของพลาทินัมทีแท็ก : สิทธิบัตรยา1. Gem Citabine - [Phenyl-Benzoxi-L-Alanilan)] - Phosphate, or salt or solvette of The drug is acceptable for use in the treatment of holistic cancer with Cancer additives based on platinum T Tag: Drug Patents.
TH1801003732A 2016-12-21 GEMSITABINE - [Phenyl-Benzoxi-L-Alanilan)] - Phosphate, or salts or solvets of such things that are pharmacologically acceptable for use in Cancer treatment and the aforementioned holistic packages TH1801003732A (en)

Publications (1)

Publication Number Publication Date
TH1801003732A true TH1801003732A (en) 2020-07-27

Family

ID=

Similar Documents

Publication Publication Date Title
TH1801003732A (en) GEMSITABINE - [Phenyl-Benzoxi-L-Alanilan)] - Phosphate, or salts or solvets of such things that are pharmacologically acceptable for use in Cancer treatment and the aforementioned holistic packages
TH1801007603A (en) 1-Tetrahydropyranil Carbonyl-2,3-Dihydro-1H-Indole Compound for Cancer Treatment
TH1701001069A (en) Tetrahydro-naphthalene derivatives that inhibit MCL-1 protein.
TH1701001929A (en) Substitudate aminopureine compounds, their constituents, and their treatment methods
TH1701007724A (en)
TH1801001962A (en) GEMSITABINE-[PHENYL-BENZCY-L-ALANINIL)] - Phosphate and platinum-based anti-cancer agent for cancer treatment.
TH1501005024A (en) Pharmaceutical constituents for the treatment of fungal infections.
TH171283A (en) Tetrahydropyrolothiazine
TH166749A (en) New pyrolopyrimidine compounds Or salt of that substance Pharmaceuticals containing the same substance, in particular for the prevention and / or treatment of tumors and others that rely on NAE inhibitory effects.
TH1501005021A (en) The use of pyrazolypirimidine derivatives for the treatment of PI3K-related disorders (delta).
TH1601003241A (en) Use of benzimidazole-proline derivatives
TH1701002032A (en) The use of neridronic acid or its salts for the treatment of osteomyelitis.
TH1701005228A (en) Kv1.3 inhibitors and their medical applications
TH1701006100A (en) Pyridopyrimidenone and its use
TH1601006420A (en) The IGF-1R antibody and its use are referring to the drug for the treatment of cancer.
TH1601004396A (en) Heteroaryyl amide that inhibits the aggregation of proteins.
TH178179S (en) "Data check machine"
TH180207A (en) Improved stability of glucagon derivatives (GLUCAGON DERIVATIVES).
TH155936S (en) chair
TH1601003681A (en) Applications of isosazoline compounds in poultry
TH1701007762A (en) 2,3-dihydro-4H-1,3-benzoxacin-4-transfer derivative. The muscharinic M1 receptor is the controller of the Colinergic.
TH1701004168A (en) Elements that can be dispersed
TH1701005019A (en) Bicyclic, ketone, sulfonamide compounds
TH1601000693A (en) Early-release dosage form for JAK1 inhibitors.
TH1501003881A (en) Benzylamine derivatives